Skip to main content
. 2013 Dec 10;22(2):371–377. doi: 10.1038/mt.2013.257

Figure 1.

Figure 1

In vivo optical imaging to assess anticancer efficacy of DZ1 with or without radiation therapy (IR) in NPC xenograft model. (a) Luciferase-expressing CNE1-LMP1 (CEN-1-LMP1-Luc-DsRED) tumor-bearing mice were monitored by bioluminescence imaging at day 2 and day 18 after first injection. (b) In vivo average optical signal intensity expressed as photons acquired per second in regions of interest (ROI). Optical signals from the ROI are expressed as mean ± SE, *P > 0.05, **P > 0.01. LMP1, latent membrane protein-1.